Description de l'entreprise
The biopharmaceutical company co.don AG based near Berlin is one of the leading specialists worldwide in cell cultivation for the regenerative treatment of articular cartilage defects and spinal disc defects. The company's patented pharmaceutical products are used to treat cartilage damage. Left untreated, cartilage defects can often result in joint replacement surgery.
Conseil d'administration & Conseil de surveillance
| PDG |
| - |
| Conseil d'administration |
| Dr. Achim Simons, Tilmann Bur |
| Conseil de surveillance |
| Prof. Hans B. Bauerfeind, Thommy Stählin, Beatrix Bauerfeind-Johnson, Prof. Dr. Barbara Sickmüller, Prof. Dr. Hans-Jörg Bullinger, Thomas Krause |
Données de l'entreprise
| Nom: |
Co.don AG |
| Adresse: |
Warthestraße 21,D-14513 Teltow |
| Téléphone: |
+49-3328-4346-0 |
| Fax: |
+49-3328-4346-43 |
| Courriel: |
info@codon.de
|
| Internet: |
www.codon.de |
| Industrie: |
Biotechnology |
| Secteur: |
Biotechnology |
| Sous-secteur: |
Biotechnology |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
41.56% |
| IPO date: |
14/02/2001 |
Relations avec les investisseurs
| Nom: |
Matthias Meißner |
| Téléphone IR: |
49-30-2403-52-330 |
| IR-Fax: |
- |
| E-mail IR: |
ir@codon.de
|
